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Summary.-Experiments were undertaken to investigate the early effects of DMBA
or progesterone, or the two in combination, on DNA synthesis in rat mammary
epithelial cells, and also to determine whether there was any correlation between
the level of DNA synthesis observed in the first 96 hours after administration of
DMBA, either alone or combined with progesterone, and subsequenttumour develop-
ment.
It was found that DMBA alone caused an insignificant reduction in DNA synthesis
in the first 96 hours, whereas progesterone significantly enhanced DNA synthesis.
When the carcinogen and hormone were administered together, a greater rise was
seen in the level of DNA synthesis than that occurring in rats treated only with
DMBA, but the increase was not significantly greater than that in untreated animals.
Atwo-way analysis ofvariance revealed no interaction betweenDMBAand progester-
one in relation to mammary epithelial cell DNA synthesis.
Mammary neoplasms occurred only in the groups of rats which had received
DMBA, either alone or in combination with progesterone. No correlation could
be demonstrated between the extent of DNA synthesis observed in mammary glands
biopsied between 6 and 96 hours after carcinogen administration and the occurrence
oftumours in the host rats 135 days later.
PREVIOUS investigations have shown
that exogenous progesterone, while not
carcinogenic per se, significantly enhanced
7,12-dimethylbenz(a)anthracene (DMBA)
mammary carcinogenesis in entire rats
when hormone injections were begun
either 2 days before or just after carcino-
gen administration (Jabara, 1967; Jabara
andHarcourt, 1970). Incontrast, Welsch,
Clemens and Meites (1968) reported that
prolonged (25 days) treatment with pro-
gesterone before administering DMBA
significantly inhibited mammary tumori-
genesis. They suggested that the en-
hanced mammary development induced
by prolonged progesterone pretreatment
rendered the gland relatively refractory
to carcinogen action. DNA synthesis
hasbeenreportedtobe markedlydepressed
in rat mammary gland for at least 4 days
after administration of DMBA alone
(Shimkin et al., 1967; Tominaga, Libby
and Dao, 1970). Marquardt, Bendich
and Philips (1971) have shown that while
DMBA will bind to hepatocyte non-
replicating DNA, the amount of bound
DMBA increases three-fold during DNA
synthesis, and Brookes and Lawley (1964)
observed a close correlation between
carcinogenicity and the amount of hydro-
carbon bound to DNA in mouse skin.
These observations suggest that the
contrasting effects on DMBA mammary
carcinogenesis of long or short pretreat-
ment with progesterone might be related
to the level ofDNA synthesis in the glands
at the time of feeding DMBA.
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TABLE, I.-Average
Mammary Epithe
Cells per C'ontrol
Different Stages o
Oestrous cycle Nu
stage of
Pro-oestrus
(stage 1)
Oestrus
(stages 2 and 3)
Metoestrus
(stage 4)
Dioestrus
(stage 5)
MATERIALS I
Treatment of animals
One hundred and
Sprague-Dawley fem
(35-55 g body weight)
early effects on DNA into 6 groups (Tables I and II), housed 5
ary epithelial cells of rats per cage and fed commercial pellets
,d alone or combined and water ad libitum. Rats in Group 1
t pretreatment with served as untreated controls. Each animal
2) whether there was in Groups 3-6 received daily subcutaneous 2wheenther exthen os injections of 3 mg of progesterone (Sigma tween the extent of Chemical Co., U.S.A.) dissolved in 0-1 ml of )served in the first corn oil. In Groups 3 and 5, hormone
Iministration of tho injections were begun on their 25th day of
[one or combined with age (P-25), and in Groups 4 and 6 on their
subsequent tumour 48th day of age (P-2), i.e. 25 and 2 days,
respectively, before feeding the carcinogen;
injections were continued until the pre-
Number of Labelled determined times for removal of mammary
hial Nuclei per 2000 tissue were reached (Table II). In addition,
Rat (Group 1) in the at 50 days of age each rat in Groups 5 and 6,
f the OestroU8 Cycle as well as those in Group 2, was fed intra- r the Oestrougs Cycle gastrically a single 30 mg dose of DMBA
Average number (Eastman Organic Chemicals, U.S.A.) dis-
labelled nuclei solved in 2 ml of corn oil (Table II). Daily
Lmber per 2000 cells
Frats per rat ± S.D. vaginal smears were taken from all rats,
6 . 67±128-2 beginning between their 45th and 50th day of age, for at least 2 complete oestrous cycles
7 . 30±25-4 (Group 1) and for at least 3 complete cycles
(Groups 2-6).
5 . 50±51-9 Two hours before removing the 2 most
posterior mammary glands on the left side,
6 . 83±103-9 150 ,Cioftritiatedthymidine (Radiochemical
Centre, Amersham) (specific activity 5*0
Ci/mmol/l) made up to 1 ml in sterile 0-9%
AND METHODS saline solution was injected intraperitoneally. In Groups 2-6 the thymidine was injected one
hour before the predetermined times of 6,
thirty-eight non-inbred 12, 24, 36, 48, 72 and 96 hours and the
ale rats aged 25 days mammary tissue was removed one hour after
>were divided randomly these times. Mammary tissue was usually
TABLE II.-Treatments Used and the Resulting Average Number of Labelled Mammary
Epithelial Nuclei per 2000 Cells per Rat between 6 and 96 hours and the Group
Average
Group treatment
Total no. rats
Removal of mammary tissue:
No. rats biopsied
No. rats autopsied
No. labelled nuclei per 2000 cells per rat*
6 hours
12 hours
24 hours
36 hours
48 hours .
72 hours
96 hours
Group average
Within group standard deviation
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
DMBA DMBA
Nil DMBA P-25 P-2 P-25
24 . 25 . 21 . 21 23
0
24
P-2
24
17 . 16 . 13 . 18 16
8 5 . 8 . 5 8
29
34
25
73
40
36
581
57 44
86-8 . 81-1
132
56
83
76
134
58
141
97
69-3
182
32
21
46
148
147
99
96
104-5
111
48
59
102
58
18
87t
70
58-9
83
46
123
115
34
49
107§
83
80-8
* Each time interval represents the average of 3 rats, except: t average of 7 rats, $ average of 5 rats,
§ average of 6 rats.
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FIG. 1. Autoradiograph of mammary tissue removed from a rat in Group 4 (P-2) at 48 hours (52
days of age), showing the presence of labelled nuclei in epithelial cells lining small ducts and
alveoli. Kernechtrot/Tartrazine stain. x 600.
removed by surgical biopsy, but, as part of a
preliminary experiment, some animals in
each group were killed and the mammary
tissue removed at autopsy (Table II).
Biopsied rats were permitted to survive until
their 185th day of age, i.e. 135 days after
feeding the carcinogen. In the control
animals, tritiated thymidine was injected
intraperitoneally 2 hours before killing rats
in the different stages of the oestrous cycle;
the 2 most posterior mammary glands on the
left side were removed at autopsy (Table I).
Preparation of autoradiographs
Excised mammary tissue was flattened
on a thin card and fixed in 10% buffered
formalin. Serial sections, 4 ,um thick, were
cut from each paraffin block and, to avoid
counting the same cell twice, only every
fourth section was used. Three sections per
slide were mounted well towards one end ofit,
dried and deparaffinized. The slides were
then dipped, under a Ilford safety light
No. 904F, in Ilford K5 nuclear emulsion dilu-
ted 1 in 4 with metal distilled water and
maintained at 46°C. After drying the slides
for 1-2 hours in a black, dustproof, Perspex
box, the slides were sealed in lightproof slide
boxes (Clay-Adams Inc.) and exposed at
4°C. To allow for variation in labelling
intensity, half the slides were developed in
Agfa Neutol S after20 days and theremainder
after 40 days (Fig. 1). The sections were
stained with 0X1% Kernechtrot (Chroma)
in a 5% aluminium sulphate solution,
counterstained with 2.5% tartrazine cellu-
solve (Chroma) and mounted in polystyrene.
Examination ofautoradiographs
An adaptation of a random field method
described by Fitzgerald et al. (1968) was used
for counting the labelled and unlabelled
mammary epithelial cells. The mammary
tissue section was moved by the mechanical
stage, while being viewed at low power,
and the vernier numbers on the stage
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FiIG. 2. A diagrammatic representation of a section of mammary tissue and overlying skin, showing
the constIuction of a randomized set of lines which were then used for counting an autoradiograph.
A new randomized set of lines was constructed for each tissue section counted.
corresponding to the lateral limits of the
tissue were determined. The consecutive
whole numbers falling between these 2
limits were then recorded (Fig. 2). A deci-
mal point was added to the rightofeach whole
number and a sequence of random numbers,
drawn from a table of random numbers,
was added successively to the right of each
decimal point to form a randomized set of
lines over the entire section (Fig. 2). Be-
cause the mammary tissue sections were long
and narrow, unlike Fitzgerald et al. (1968)
only one set of randomized lines was used,
and all the epithelial cells encountered
along each line were counted with the oil
immersion objective. For each rat, 500
epithelial cells were counted from sections
exposed for 20 days and, depending on the
labelling intensity, a further 1500 cells
from the same animal were counted from
sections exposed for either 20 or 40 days;
the number of labelled nuclei per 2000 cells
per rat was recorded in 4 x 500 cells. An
individual cell was considered to be labelled
when at least 10 more silver grains were
localized over the nucleus than were observed
over an equivalent area of background;
background labelling in almost all prepara-
tions was negligible.
Treatment of tumour tissue
Surviving animals in Groups 2-6 were
sacrificed at 185 days of age. Portions of
each tumour w%Aere removed at autopsy,
fixed in 10% buffered formalin and 5 um
paraffin sectionswerestainedwithhaematoxy-
lin and eosin.
Statistical methods
For convenience, the sum of 4 estimations
of the number of labelled epithelial nuclei
per 500 cells is referred to as the LEN.
The LEN for each rat is therefore an estimate
of the number of labelled epithelial nuclei
per 2000 cells.
An analysis of variance was used to test
for the possible effects on the LEN of each
of the following: stage of oestrous cycle,
time of mammary biopsy, DMBA, progester-
one, and DMBA combined with progesterone.
For each of these analyses, the logarithm
of the LEN for each rat was used because
scatter diagrams suggested this to be the
most appropriate transformation in stabili-
zing the variance of an observation. A
variance analysis of ranked data (Kruskal
and Wallis, 1952) was used to test for a
possible relationship between the LEN and
subsequent tumour occurrence and also to
test for possible differences between treat-
ment groups with respect to the average
number of active tumour centres developed
per rat. x2 tests to contingency tables were
used to analyse possible differences in
tumour incidence and tumour multiplicity
among different treatment groups.
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RESULTS
Effect of oestrous cycle on LEN
In the controls (Group 1) the average
LEN per rat differed with the stage of
the oestrous cycle, but these differences
were not statistically significant, pre-
sumably due to the large variability of
observations within each group (Table I).
Therefore, in analyses of treated animals
(Groups 2-6) the stage of the oestrous
cycle was disregarded. At the time of
mammary gland removal most of the
treated rats were in dioestrus, except
for 4 rats in Group 3 and one rat in Group
.5 whose vaginae had not opened and 6
rats in Group 2 which were in either pro-
oestrus or oestrus. Continuation of vag-
inal smearing for 2-3 weeks after taking
mammary biopsies revealed that rats in
Group 2 (DMBA only) continued to
cycle normally in either a 4 or 15) day
cycle, while animals in Groups 3-6,
whichl had received progesterone up) to
the time of inammary gland removal,
continued in dioestrus for approximately
a further 10 days before they began to
cycle normally.
Effect of time of tissue saimpliny on LEN
Within each group of treated rats
(Groups 2-6) the LEN varied from one
time interval to another (Table II), but
these differences were not significant.
The time of tissue sampling was therefore
disregarded in other ainalvses.
Effects ofDlMBA and )royesterone on LEN
The LEN (averageofallrats in a group)
for animals fed only DMBA (Group 2)
was lower than that obtained for the
controls (Group 1) and those obtained
for rats receiving only progesterone
(Groups 3 and 4) (Table II). Analysis
revealed that while the difference between
the LENs in the former 2 groups was not
significant (P > 0-10), the differences
between Group 2 and each of the latter 2
progesterone-treated groups (3 and 4) were
significant (P < 0 005 and P < 0*025,
respectively). Progesterone significantly
20
increased the LEN not only compared
with that in the DMBA-treated rats, but
also compared with the untreated controls
(Group 1), regardless ofwhether injections
were begun at 25 or 48 days of age
(P < 0u(1 and P < 0 05, respectively)
(Table II). The difference between the
LENs in the 2 hormnone-treated groups
(3 and 4) was not significant (Table II).
Effects of co?nbined DMBA/progesterone on
LEN
In the rats treated with both carcino-
gen and hormone, the LEN for Group 5
(DMBA + P-25) was lower, but not
significantly so, than that for Group 6
(DMBA + P-2) (Table II), and neither
of these LENs was significantly higher
than that obtained for the controls
(Group 1), the difference between the
LENs for Group 1 and 6 just failinig to
reach significance at th-e 5% level
(P 0.051). However, the LENs for
Groups 5 and 6 were both significantly
higher than that obtained for Group 2
(DMBA only) (P < 0-01 and P < 0*025,
respectively) (Table II). The LEN for
Group 5 (DMBA 4- P-25) was not signifi-
cantly different from that obtained in
Group 3 (P-25), and, similarly, the LEN
for Group 6 (DMBA + P-2) was not sig-
nificantly different from that obtained in
Group 4 (P-2) (Table II). The possibility
of an interaction between I)MBA and
progesterone in relation to the LEN was
tested by means of a two-way analysis of
varianice. The result was not significant
(P > 0.10), indicating that the effect due
to DMBA did not appear to vary with the
presence or absence of progesterone, and
likewise the relative effect due to pro-
gesterone appeared to be independent of
the presence or absence of DMIBA.
Effects of treatrnent 'egimrnens on tumour
yield
Mammuary tumours arose only in
Groups 2, 5 and 6 which had received
DMBA, either alone or in combination
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TABLE III.-Treatments Used and the Resulting Mammary Tumour Incidences,
Number of Rats with Multiple Tumours and Histological Tumour Types Induced
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
DMBA DMBA
± ±
Group treatment Nil DMBA P-25 P-2 P-25 P-2
vivors after mammary gland removal 0 17 16 13 . 18 . 16
vivors at end of experiment . 0 12 . 16 13 17 16
of rats with tumours . 6 . 0 . 0 . 7 . 9
ercentage) . . (50*0) - . (41*2) (56*3)
al no. of tumours . . 17 . 0 . 0 10 24
of rats with multiple* tumours - 4 0 0 2 . 6
ercentage) . . . - (33-3) . . (11-8) (37 5)
rage no. ofactive tumour centres per rat . - 14 . 0 . 0 06 15
Histological tumour types
No. classified carcinoma
No. classified adenoma
* Two or more tumours per rat.
with progesterone (Table III). All biop-
sied rats within these 3 groups survived,
with the exception of 5 animals in Group
2 which died 55 days after carcinogen
administration, due to a failure in the
automatic watering system over a holiday
period, and one rat in Group 5 which died
from pneumonitis 105 days after receiving
DMBA. None of these 6 rats bore pal-
pable tumours at death and, from a pre-
vious series, these times were considered
to be too short for the development of
palpable neoplasms (unpublished data).
Hence, all figures and statistics relating
to tumour yield have been based only on
the rats which survived to the end of the
experiment (135 days after feeding
DMBA).
The tumour incidence, numbers ofrats
developing multiple tumours and the
average number of active tumour centres
developed per rat varied between the 3
groups, appearing lowest in Group 5
(Table III), but none of these differences
was statistically significant.
Relationship between LEN and tumour
development
To test for a possible relationship
between the LEN and subsequent tumour
occurrence, the rats were divided into 2
grqups (a) those with a LEN of less than
40 and (b) those with a LEN of greater
than 40, and in addition the rats were
paired into identical time and treatment
17 0 . 0 . 10 . 23
0 . 0 . 0 . 0 1
groups in an attempt to eliminate any
effect due to these two variables. This
necessitated randomly deleting 17 of the
45 rats in Groups 2, 5 and 6 from the
analysis. The Kruskal and Wallis (1952)
test demonstrated no evidence of any
relationship between the LEN observed
in mammary glands biopsied between 6
and 96 hours after DMBA administra-
tion and the observed occurrence of tum-
ours in the host rats (Groups 2, 5 and 6)
135 days later (P > 010).
With the exception of an adenoma
arising in one rat in Group 6, histologically
all the neoplasms were carcinomata
(Table III), the majority being adeno-
carcinomata and the remainder of a
solid, poorly differentiated type (Jabara,
1967).
DISCUSSION
Thymidine is incorporated only into
cells undergoing DNA synthesis (Reichard
and Estborn, 1951; Friedkin, Tilson and
Roberts, 1956), so that the number of
cells labelled with tritiated thymidine per
2000 gives an estimate of the number of
cells undergoing DNA synthesis at the
particular time of tissue sampling.
Shimkin et al. (1967) and Tominaga,
Libby and Dao (1970) reported a signifi-
cant depression in DNA synthesis in
mammary epithelial cells up to 96 hours
after feeding DMBA. In the present
series, there was a trend towards a
Sur
Sun
No.
(P
TotE
No.
(P
Avei
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depression in mammary epithelial DNA
synthesis between 6 and 96 hours follow-
ing administration of DMBA alone, but
the level of DNA synthesis was not
significantly reduced below control levels.
Analysis of the 3 experiments revealed
no obvious reason for this difference, and
the explanation may possibly lie in the
use of a more resistant substrain of
Sprague-Dawley rat in the present series.
In contrast to DMBA, progesterone
significantly increased DNA synthesis in
the 6-96 hour period above control
levels, regardless of whether injections
were begun at 25 or 48 days of age.
Similarly, administration of DMBA com-
bined with either long or short progester-
one pretreatment, resulted in an increase
in DNA synthesis above both control
(an insignificant rise) and DMBA values
(a significant increase). Furthermore, a
subjective histological assessment ofmam-
mary development in the 6 groups re-
vealed that although there was consider-
able individual variation in the extent
of lobular-alveolar development, glandu-
lar development was similar in the 4
progesterone-treated groups, and was
greater than that seen in the glands from
the controls and DMBA-treated rats.
The similarity in both the level of DNA
synthesis and the extent of mammary
gland development in rats given long or
short progesterone treatments before feed-
ing DMBA, fails to confirm the suggestion
advanced by Welsch, Clemens and Meites
(1968) that enhanced mammary develop-
ment renders the gland refractory to
DMBA and results in decreased tumori-
genesis following prolonged progesterone
pretreatment. In the present series, there
is a trend towards a lower overall tumour
yield in Group 5 (DMBA + P-2), but
the difference is not significant. Dao
(1969) has suggested that under strong
hormonal stimulation interaction between
polycyclic hydrocarbons and hyperfunc-
tioning mammary epithelial cells may
be inhibited. It would be of interest to
investigate the amounts of DMBA bound
to mammary epithelial cell macromole-
cules derived from virgin, pregnant and
progesterone-treated animals.
Several studies on mouse skin have
suggested that DNA synthesis may be
important in DMBA carcinogenesis (Frei
and Harsono, 1967; Bates Ut al., 1968;
Hennings et al., 1968; Pound, 1968;
Suss and Maurer, 1968). Other investiga-
tions, however, have been unable to
demonstrate a direct relationship between
the early inhibitory effect of DMBA on
DNA synthesis and tumour yield in
mouse skin (Goshman and Heidelberger,
1967; Hennings and Boutwell, 1969),
and a similar conclusion has been reached
in relation to DMBA mammary car-
cinogenesis (Shimkin etal., 1967;Tominaga
et al., 1970). In the latter 2 experiments,
the conclusion was based on the finding
that DMBA decreased tritiated thymidine
incorporation into mammary gland DNA
not only in females but also in male rats,
and yet, unlike females, male rats rarely
develop mammary neoplasms following
administration of a single dose of the
carcinogen. Findings in the present series
not only confirm this conclusion, but
further suggest that no direct relation-
ship exists between DNA synthesis and
subsequent tumour yield, regardless of
whether DNA synthesis is increased or
decreased close to the time of DMBA
administration.
In rat mammary gland and mouse
skin, DMBA binds not only to DNA
but also to RNA and proteins (Flesher,
1967; Goshman and Heidelberger, 1967;
Janss, Moon and Irving, 1971), and recent
work suggests that early events in mam-
mary carcinogenesis may be related to the
effects of DMBA on DNA-dependent
RNA polymerase activity (Tominaga et
al., 1971). These investigators observed
a significant decrease in activity of this
enzyme for 2 days after DMBA adminis-
tration to female rats, and activity then
increased to a level significantly above
control values by 4 days. No depression
in RNA polymerase activity occurred in
male rats fed DMBA. These findings
substantiate the alterations in RNA
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synthesis reported by Libby and Dao
(1966) in female rat mammary glands
within the same 4-day period. They also
found that the depression in RNA syn-
thesis occurred only in females and was
dependent on the presence of ovarian
steroids, particularly oestrogen.
During pseudopregnancy, a progesta-
tional state, both DNA and RNA syn-
thesis have been shown to be significantly
enhanced in rat mammary tissue (Sinha
and Schmidt, 1969). While the effect
ofcombined DMBA/progesterone adminis-
tration on rat mammary gland RNA
synthesis is not yet known, the present
experiments failed to show any interac-
tion between the carcinogen and hormone
in relation to mammary epithelial cell
DNA synthesis. This suggests that the
two agents may be acting at separate sites
within the mammary epithelial cell.
Previous work, supporting this suggestion,
has shown that while progesterone is a
potent promotor of DMBA mammary
carcinogenesis when administered close
to the time of feeding the carcinogen,
its presence does not appear to be essential
for cancerinduction(JabaraandHarcourt,
1970, 1971). However, whether the
carcinogen and hormone act initially at
the transcriptional or translational level,
or at both, is not yet certain. O'Malley
and Toft (1971) and Spelsberg, Steggles
and O'Malley (1971) have recently shown
that tritiated progesterone is complexed
with a cytosol receptor protein in chick
oviduct and then transported to the
nucleus where the progesterone-receptor
complex binds to non-histone acidic
proteins of oviduct chromatin. Whether
progesterone also acts directly on rat
mammary tissue in this way is unknown.
Available evidence suggests that pro-
gesterone may stimulate breast tissue
indirectly via the hypothalamus and
pituitary gland, the effect being due to
increased secretion of prolactin (LTH)
and possibly also growth hormone (STH)
(Huggins, Mainzer and Briziarelli, 1958;
Rothchild, 1960; Kim, 1965; Clementi
and De Virgiliis, 1967; Hervey and
Hervey, 1967; Sar and Meites, 1968;
Welsch et al., 1968). Both LTH and
STH have been shown to stimulate
markedly mammary growth in rats,
even in the absence of the pituitary
gland and ovaries (Furth and Clifton,
1957; Talwalker and Meites, 1961; Dao
and Gawlak, 1963; Talwalker, Meites
and Mizuno, 1964; Sinha and Tucker,
1968; Takizawa, Furth and Furth, 1970).
Experiments are in progress in this labora-
tory to clarify this point.
The authors wish to thank Mr J. S.
Maritz, Department of Statistics, Univer-
sity of Melbourne, for help with the
statistical analysis. This work was car-
ried out during the tenure of a grant
from the Anti-Cancer Council of Victoria
to one of us (A.G.J.).
REFERENCES
BATES, R. R., WORTHAM, J. S., COUNTS, W. B.,
DINGMAN, C. W. & GELBOIN, H. V. (1968)
Inhibition by Actinomycin D of DNA Synthesis
and Skin Tumorigenesis Induced by 7,12-
dimethylbenz(a)anthracene. Cancer Res., 28, 27.
BROOKES, P. & LAWLEY, P. D. (1964) Evidence for
the Binding of Polynuclear Aromatic Hydro-
carbons to the Nucleic Acids of Mouse Skin:
Relation between Carcinogenic Power of Hydro-
carbons and Their Binding to Deoxyribonucleic
Acid. Nature, Lond., 202, 781.
CLEMENTI, F. & DE VIRGILIIS, G. (1967) Ultrastruc-
ture of the Adenohypophysis after Ovariectomy
and Treatment with Oestrogens and Progester-
one. Path. Biol. Paris., 15, 119.
DAO, T. L. (1969) Studies on Mechanism of Car-
cinogenesis in the Mammary Gland. Prog.
exp. Tumor Res., 11, 235.
DAO, T. L. & GAWLAK, D. (1963) Direct Mammo-
trophic Effect of a Pituitary Homograft in Rats.
Endocrinology, 72, 884.
FITZGERALD, P. J., CAROL, B., LIPKIN, L. &
ROSENSTOCK, L. (1968) Pancreatic Acinar Cell
Regeneration. V. Analysis of Variance of the
Autoradiographic Labeling Index (Thymidine-
H3). Am. J. Path., 53, 953.
FLESHER, J. W. (1967) Distribution ofRadioactivity
in the Tissues of Rats after Oral Administration
of 7,12-dimethylbenz(a)anthracene-3H. Biochem.
Pharmac., 16, 1821.
FREI, J. V. & HARSONO, T. (1967) Increased Sus-
ceptibility to Low Doses of a Carcinogen of
Epidermal Cells in Stimulated DNA Synthesis.
Carncer Res., 27, 1482.
FRIEDKIN, M., TILSON, D. & ROBERTS, D. (1956)
Studies of Deoxyribonucleic Acid Biosynthesis
in Embryonic Tissues with Thymidine-C'4.
J. biol. Chem., 220, 627.AN AUTORADIOGRAPHIC STUDY 273
FURTH, J. & CLIFTON, K. H. (1957) Experimental
Pituitary Tumors and the Role of Pituitary
Hormones in Tumorigenesis of the Breast and
Thyroid. Cancer, N.Y., 10, 842.
GoSHMAN, L. M. & HEIDELBERGER, C. (1967)
Binding of Tritium-labeled Polycyclic Hydro-
carbons to DNA of Mouse Skin. Cancer Re8.,
27, 1678.
HENNINGS, H. & BOUTWELL, R. K. (1969) The
Inhibition of DNA Synthesis by Inhibitors of
Mouse Skin Tumorigenesis. Cancer Res., 29,
510.
HENNINGS, H., SMITH, H. C., COLBURN, N. H. &
BOUTWELL, R. K. (1968) Inhibition byActinomycin
D of DNA and RNA Synthesis and of Skin
Carcinogenesis Initiated by 7,12-dimethylbenz-
(a)anthracene or ,B-propiolactone. Cancer Res.,
28, 543.
HERVEY, E. & HERVEY, G. R. (1967) The Effects
of Progesterone on Body Weight and Composition
in the Rat. J. Endocr., 37, 361.
HuGGaINS, C., MAINZER, K. & BRIZIARELLI, G.
(1958) Molecular Structure of Steroids and
Phenanthrene Derivatives Related to Growth
of Transplanted Mammary Tumors. Recent
Prog. Horm. Res., 14, 77.
JABARA, A. G. (1967) Effects of Progesterone on
9,10-dimethyl-1,2-benzanthracene-induced Mam-
mary Tumours in Sprague-Dawley Rats. Br.
J. Cancer, 21, 418.
JABARA, A. G. & HARCOURT, A. G. (1970) The
Effects of Progesterone and Ovariectomy on
Mammary Tumours Induced by 7,12-dimethyl-
benz(a)anthracene in Sprague-Dawley Rats.
Pathology, 2, 115.
JABARA, A. G. & HARCOURT, A. G. (1971) Effects
of Progesterone, Ovariectomy and Adrenalectomy
on Mammary Tumours Induced by 7,12-dimethyl-
benz(a)anthracene in Sprague-Dawley Rats.
Pathology, 3, 209.
JANSS, D. H., MOON, R. C. & IRVING, C. C. (1971)
Persistent Binding of 7,12-dimethylbenz(a)-
anthracene (DMBA) to Rat Mammary Gland
DNA in vivo. Proc. Am. As8. Cancer Res., 12,
64.
KIM, U. (1965) Pituitary Function and Hormonal
Therapy of Experimental Breast Cancer. Cancer
Res.,25, 1146.
KRUSKAL, W. H. & WALLIS, W. A. (1952) Use of
Ranks in One-criterion Variance Analysis. J.
Am. stat. Ass., 47, 583.
LIBBY, P. R. & DAO, T. L. (1966) Rat Mammary
Gland RNA: Incorporation of C14-formate and
Effect of Hormones and 7,12-dimethylbenz(a)-
anthracene. Science, N.Y., 153, 303.
MARQUARDT, H., BENDICH, A. & PHILIPS, F. (1971)
DNA Binding and Synthesis in Regenerating
Liver of Rats given 7,12-dimethylbenz(a)-
anthracene (DMBA) during Prereplicative Phase.
Proc. Am. Ass. Cancer Res., 12, 15.
O'MALLEY, B. W. & TOFT, D. 0. (1971) Progesterone-
binding Components of Chick Oviduct. II.
Nuclear Components. J. biol. Chem., 246, 1117.
POUND, A. W. (1968) The Influence of Preliminary
Irritation by Acetic Acid or Croton Oil on Skin
Tumour Production in Mice after a Single Applica-
tion of Dimethylbenzanthracene, Benzopyrene,
or Dibenzanthracene. Br. J. Cancer, 22, 533.
REICHARD, P. & ESTBORN, B. (1951) Utilization of
Desoxyribosides in the Synthesis of Poly-
nucleotides. J. biol. Chem., 188, 839.
ROTHCHILD, I. (1960) The Corpus Luteum-
Pituitary Relationship: the Association between
the Cause of Luteotrophin Secretion and the
Cause of Follicular Quiescence during Lactation;
the Basis for a Tentative Theory of the Corpus
Luteum-Pituitary Relationship in the Rat.
Endocrinology, 67, 9.
SAR, M. & MEITES, J. (1968) Effects ofProgesterone,
Testosterone, and Cortisol on Hypothalamic
Prolactin-inhibiting Factor and Pituitary Pro-
lactin Content. Proc. Soc. exp. Biol. Med., 127,
426.
SHIMKIN, M. B., GRUENSTEIN, M., THATCHER, D.
& BASERGA, R. (1967) Tritiated Thymidine
Labeling of Cells in Rats following Exposure
to 7,12-dimethylbenz(a)anthracene. Cancer Res.,
27, 1494.
SINHA, Y. N. & SCHMIDT, G. H. (1969) Changes in
Pituitary Prolactin and Mammary Nucleic
Acid Content during Pseudopregnancy in the Rat.
Proc. Soc. exp. Biol. Med., 130, 867.
SINHA, Y. N. & TUCKER, H. A. (1968) Pituitary
Prolactin Content and Mammary Development
after Chronic Administration of Prolactin. Proc.
Soc. exp. Biol. Med., 128, 84.
SPELSBERG, T. C., STEGGLES, A. W. & O'MALLEY,
B. W. (1971) Progesterone-binding Components
of Chick Oviduct. III. Chromatin Acceptor
Sites. J. biol. Chem., 246, 4188.
Suss, R. & MAURER, H. R. (1968) Reduced Binding
of Carcinogenic Hydrocarbons to DNA of Mouse
Skin during Inhibition of DNA Synthesis.
Nature, Lond., 217, 752.
TAKIZAWA, S., FURTH, J. J. & FURTH, J. (1970)
DNA Synthesis in Autonomous and Hormone-
responsive Mammary Tumors. Cancer Res.,
30, 206.
TALWALKER, P. K. & MEITES, J. (1961) Mammary
Lobulo-Alveolar Growth Induced by Anterior
Pituitary Hormones in Adreno-Ovariectomized
and Adreno-Ovariectomized-Hypophysectomized
Rats. Proc. Soc. exp. Biol. Med., 107, 880.
TALWALKER, P. K., MEITES, J. & MIzuNo, H.
(1964) Mammary Tumor Induction by Estrogen
orAnterior Pituitary Hormones in Ovariectomized
Rats given 7,12-dimethyl-1,2-benzanthracene.
Proc. Soc. exp. Biol. Med., 116, 531.
TOMINAGA, T., LIBBY, P. R. & DAO, T. L. (1970)
An Early Effect of 7,12-dimethylbenz(a)anthra-
cene on Rat Mammary Gland DNA Synthesis.
Cancer Res., 30, 118.
TOMINAGA, T., DAO, T. L. & LIBBY, P. R. (1971)
Effects of 7,12-dimethylbenz(a)anthracene on
RNA Polymerase in Isolated Mammary Gland
Cell Nuclei. Proc. Soc. exp. Biol. Med., 136,
694.
WELSCH, C. W., CLEMENS, J. A. & MEITES, J.
(1968) Effects of Multiple Pituitary Homografts
or Progesterone on 7,12-dimethylbenz(a)anthra-
cene-induced Mammary Tumors in Rats. J.
natn. Cancer Inst., 41, 465.